325 related articles for article (PubMed ID: 31717649)
1. Differences in Osteoimmunological Biomarkers Predictive of Psoriatic Arthritis among a Large Italian Cohort of Psoriatic Patients.
Diani M; Perego S; Sansoni V; Bertino L; Gomarasca M; Faraldi M; Pigatto PDM; Damiani G; Banfi G; Altomare G; Lombardi G
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717649
[TBL] [Abstract][Full Text] [Related]
2. Differentiating Psoriatic Arthritis From Psoriasis Without Psoriatic Arthritis Using Novel Serum Biomarkers.
Cretu D; Gao L; Liang K; Soosaipillai A; Diamandis EP; Chandran V
Arthritis Care Res (Hoboken); 2018 Mar; 70(3):454-461. PubMed ID: 28586166
[TBL] [Abstract][Full Text] [Related]
3. Soluble biomarkers may differentiate psoriasis from psoriatic arthritis.
Chandran V
J Rheumatol Suppl; 2012 Jul; 89():65-6. PubMed ID: 22751596
[TBL] [Abstract][Full Text] [Related]
4. Serum level of receptor activator of nuclear factor kappa-B ligand in patients with psoriasis.
Amin TE; ElFar NN; Ghaly NR; Hekal MM; Hassan AM; Elsaadany HM
Int J Dermatol; 2016 May; 55(5):e227-33. PubMed ID: 26712216
[TBL] [Abstract][Full Text] [Related]
5. Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative study.
Jadon DR; Sengupta R; Nightingale A; Lu H; Dunphy J; Green A; Elder JT; Nair RP; Korendowych E; Lindsay MA; McHugh NJ
Arthritis Res Ther; 2017 Sep; 19(1):210. PubMed ID: 28934972
[TBL] [Abstract][Full Text] [Related]
6. IL-6 Gene Expression as a Marker of Pathological State in Psoriasis and Psoriatic Arthritis.
Sobolev VV; Denisova EV; Chebysheva SN; Geppe NA; Korsunskaya IM
Bull Exp Biol Med; 2022 May; 173(1):77-80. PubMed ID: 35622251
[TBL] [Abstract][Full Text] [Related]
7. Large-scale plasma-metabolome analysis identifies potential biomarkers of psoriasis and its clinical subtypes.
Kishikawa T; Arase N; Tsuji S; Maeda Y; Nii T; Hirata J; Suzuki K; Yamamoto K; Masuda T; Ogawa K; Ohshima S; Inohara H; Kumanogoh A; Fujimoto M; Okada Y
J Dermatol Sci; 2021 May; 102(2):78-84. PubMed ID: 33836926
[TBL] [Abstract][Full Text] [Related]
8. Moesin and stress-induced phosphoprotein-1 are possible sero-diagnostic markers of psoriasis.
Maejima H; Nagashio R; Yanagita K; Hamada Y; Amoh Y; Sato Y; Katsuoka K
PLoS One; 2014; 9(7):e101773. PubMed ID: 25010044
[TBL] [Abstract][Full Text] [Related]
9. Rapidly progressive destructive arthritis in psoriatic arthritis sine psoriasis: do bone resorption marker levels predict outcome of bone destruction in psoriatic arthritis?
Taniguchi Y; Kumon Y; Shimamura Y; Kobayashi S; Terada Y
Mod Rheumatol; 2011 Feb; 21(1):106-8. PubMed ID: 20625790
[No Abstract] [Full Text] [Related]
10. Modern specific features and therapy of psoriasis and arthropathic psoriasis courses.
Syzon OO; Dashko MO; Fedorova UV
Wiad Lek; 2018; 71(2 pt 1):322-325. PubMed ID: 29729165
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of tumour necrosis factor-α and adiponectin can differentiate patients with psoriatic arthritis from those with psoriasis.
Johnson CM; Fitch K; Merola JF; Han J; Qureshi AA; Li WQ
Br J Dermatol; 2019 Aug; 181(2):379-380. PubMed ID: 30695115
[No Abstract] [Full Text] [Related]
12. Plasma YKL-40: a potential biomarker for psoriatic arthritis?
Jensen P; Wiell C; Milting K; Poggenborg RP; Østergaard M; Johansen JS; Skov L
J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):815-9. PubMed ID: 22621388
[TBL] [Abstract][Full Text] [Related]
13. Differences between psoriatic arthritis and psoriasis in multi-omics.
Gao S; Song H
Arch Dermatol Res; 2024 May; 316(6):217. PubMed ID: 38787526
[TBL] [Abstract][Full Text] [Related]
14. [Psoriatic osteopathy].
Hein G; Abendroth K; Müller A; Wessel G
Z Gesamte Inn Med; 1989 Nov; 44(22):674-7. PubMed ID: 2626847
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and differential diagnosis of psoriatic arthritis on basis of follow up of 215 cases].
Seszták M; Koó E; Farkas V; Weisz M
Orv Hetil; 1995 Apr; 136(16):811-6. PubMed ID: 7644186
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers in psoriasis and psoriatic arthritis.
Villanova F; Di Meglio P; Nestle FO
Ann Rheum Dis; 2013 Apr; 72 Suppl 2():ii104-10. PubMed ID: 23532439
[TBL] [Abstract][Full Text] [Related]
17. Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis.
Chandran V; Cook RJ; Edwin J; Shen H; Pellett FJ; Shanmugarajah S; Rosen CF; Gladman DD
Rheumatology (Oxford); 2010 Jul; 49(7):1399-405. PubMed ID: 20421218
[TBL] [Abstract][Full Text] [Related]
18. Psoriatic arthritis: a retrospective study of 162 patients.
Pavlica L; Perić-Hajzler Z; Jovelić A; Sekler B; Damjanović M
Vojnosanit Pregl; 2005 Sep; 62(9):613-20. PubMed ID: 16229202
[TBL] [Abstract][Full Text] [Related]
19. Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009.
Asgari MM; Wu JJ; Gelfand JM; Salman C; Curtis JR; Harrold LR; Herrinton LJ
Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):842-9. PubMed ID: 23637091
[TBL] [Abstract][Full Text] [Related]
20. Verna Wright Lecture: Psoriatic Arthritis: The Need for Early Intervention.
McHugh NJ
J Rheumatol Suppl; 2015 Nov; 93():10-3. PubMed ID: 26523046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
